Home › NDC Lookup › RxCUI directory › RxCUI 204430

Isoniazid 100 MG/ML Injectable Solution — RxCUI 204430

RxNorm drug concept · Semantic clinical drug
RxCUI 204430 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI204430
Official nameIsoniazid 100 MG/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asINH 100 MG/ML Injectable Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Isoniazid: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats tuberculosis (TB) caused by susceptible bacteria and is also used to prevent TB infection from becoming active disease in people at higher risk. For active TB, you will t...
  • Take it exactly as your prescriber directs, without food, since food reduces how much your body absorbs. It is usually taken daily or a few times a week. Some schedules are given w...
  • Some people have nausea, stomach upset, or tingling in the hands and feet. Mild liver enzyme rises are fairly common and are checked with blood tests. Call your doctor if the tingl...
  • Call right away for loss of appetite, nausea or vomiting, dark urine, yellow skin or eyes, belly pain on the upper right, unusual tiredness, or fever lasting more than 3 days. Also...
📖 Read our full Isoniazid guide →

🕸️ Concept Web — How Isoniazid 100 MG/ML Injectable Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Isoniazid 100 MG/ML Injectable Solution RxCUI 204430

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Isoniazid 6038
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Isoniazid Injectable Solution 370715
    • Isoniazid Injectable Product 1161933
    • Injectable Solution 316949
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Isoniazid 100 MG/ML 316106

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Isoniazid 100 MG/ML SCDC · 316106
  • Isoniazid Injectable Solution SCDF · 370715
  • Isoniazid Injectable Product SCDG · 1161933

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 204430 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00781-3056-70 1 VIAL, MULTI-DOSE in 1 CARTON (0781-3056-70) / 10 mL in 1... Isoniazid Sandoz Inc 2006-01-19
Observed labelers: Sandoz Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.